Anika Therapeutics, Inc. (ANIK) Net income 2016–2025
Anika Therapeutics, Inc. (ANIK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.0MFY2025 · since FY2016: $32.5M → -$11.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.0M | +80.4% |
| FY2024 | -$56.0M | +32.5% |
| FY2023 | -$83.0M | -453.3% |
| FY2022 | -$15.0M | -475.0% |
| FY2021 | $4.0M | +116.7% |
| FY2020 | -$24.0M | -188.2% |
| FY2019 | $27.2M | +45.2% |
| FY2018 | $18.7M | -41.2% |
| FY2017 | $31.8M | -2.2% |
| FY2016 | $32.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice